Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty.
Main Authors: | Jonathan Kimmelman, Alex John London |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-03-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC3050916?pdf=render |
Similar Items
-
Why clinical translation cannot succeed without failure
by: Alex John London, et al.
Published: (2015-11-01) -
A theoretical framework for early human studies: uncertainty, intervention ensembles, and boundaries
by: Kimmelman Jonathan
Published: (2012-09-01) -
The bench is closer to the bedside than we think: Uncovering the ethical ties between preclinical researchers in translational neuroscience and patients in clinical trials.
by: Mark Yarborough, et al.
Published: (2018-06-01) -
Better to be in The Placebo Arm for Trials of Neurological Therapies?
by: Jonathan Kimmelman
Published: (2018-04-01) -
Protected from harm, harmed by protection: ethical consequences of the exclusion of pregnant participants from clinical trials
by: Rebecca L Zur
Published: (2023-10-01)